BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/2/2024 3:59:04 AM | Browse: 218 | Download: 896
 |
Received |
|
2024-07-10 11:48 |
 |
Peer-Review Started |
|
2024-07-10 11:48 |
 |
First Decision by Editorial Office Director |
|
2024-07-23 10:38 |
 |
Return for Revision |
|
2024-07-23 10:38 |
 |
Revised |
|
2024-08-02 16:43 |
 |
Publication Fee Transferred |
|
2024-08-19 13:48 |
 |
Second Decision by Editor |
|
2024-08-19 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2024-08-19 06:16 |
 |
Articles in Press |
|
2024-08-19 06:16 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-08-23 00:10 |
 |
Publish the Manuscript Online |
|
2024-09-02 03:59 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qian-Yu Wang, Wen-Tao Zhong, Yi Xiao, Guo-Le Lin, Jun-Yang Lu, Lai Xu, Guan-Nan Zhang, Jun-Feng Du and Bin Wu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National High Level Hospital Clinical Research Funding |
2022-PUMCH-B-003 |
|
| Corresponding Author |
Bin Wu, MD, Chief Doctor, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan Road, Wangfujing, Dongcheng District, Beijing 100730, China. wubin@pumch.cn |
| Key Words |
Colon cancer; Left-sided colon cancer; Right-sided colon cancer; Pan-immune-inflammation value; Systemic inflammatory biomarkers; Prognosis |
| Core Tip |
This study underscores the critical role of tumor location in shaping the prognostic significance of the pan-immune-inflammation value in colon cancer patients. The findings reveal that a high pan-immune-inflammation value is strongly correlated with poorer disease-free survival in patients with left-sided colon cancer, while no such association was observed in right-sided colon cancer. These results suggest that integrating tumor location into prognostic evaluations could improve the identification of high-risk patients and facilitate more precise, personalized treatment strategies in clinical practice. |
| Publish Date |
2024-09-02 03:59 |
| Citation |
Wang QY, Zhong WT, Xiao Y, Lin GL, Lu JY, Xu L, Zhang GN, Du JF, Wu B. Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location. World J Gastroenterol 2024; 30(33): 3823-3836 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i33/3823.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i33.3823 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.